CheckPrescriptionChangeTask.CheckPrescriptionChange

// Job ID: #69e5c25ac21eb1a5a94fa63f
using OI.Service.HangfireTask.CheckPrescriptionChangeTask;

var checkPrescriptionChangeTask = Activate<CheckPrescriptionChangeTask>();
await checkPrescriptionChangeTask.CheckPrescriptionChange(
    "69a4c85de2638b9f120f5052",
    FromJson<Prescription>("{\"PackType\":1,\"Dose\":[],\"ShortCourseTimeslot\":[],\"PatientId\":\"69c09788c20a3af6be4af353\",\"Direction\":\"ONE every THREE months.\",\"FoilId\":\"69c09788c20a3af6be4af356\",\"FoilLabel\":\"Blister Pack 1\",\"DateDispensed\":\"2026-01-28T23:48:27Z\",\"ScriptNum\":\"60129159\",\"QtyDispense\":0.0,\"DateExpiry\":\"0001-01-01T00:00:00\",\"Route\":{\"Code\":\"IN\",\"Description\":\"Injection\"},\"IsStandard\":true,\"IsShortCourse\":false,\"IsSinemet\":false,\"IsWarfarin\":false,\"IsInsulin\":false,\"IsS8Drug\":false,\"IsCytotoxic\":false,\"IsS4N\":false,\"StartDate\":\"2026-04-20T02:00:00Z\",\"EndDate\":\"0001-01-01T00:00:00Z\",\"Frequency\":0,\"PackedWeekDay\":[],\"FreqXDay\":0,\"OnDays\":0,\"OffDays\":0,\"IsDoNotCrush\":false,\"FontColor\":\"\",\"PrintIt\":true,\"State\":1,\"DateCeased\":\"0001-01-01T00:00:00\",\"TempSubstitution\":false,\"IsHandPacked\":false,\"IsNoEndDate\":true,\"Unit\":\"\",\"PharmacyId\":\"69a4c85de2638b9f120f5052\",\"SyncDate\":\"0001-01-01T00:00:00\",\"IsSyncImported\":false,\"Drug\":{\"DrugName\":\"DEPO-PROVERA 150mg/mL, 1mL PFS\",\"DrugCode\":\"DEP4\",\"Austr\":\"\",\"Supplier\":\"PFIZER AUSTRALIA PTY LTD\",\"Type\":\"Pre-filled Syringe\",\"Color\":\"\",\"Shape\":\"\",\"Marking\":\"\",\"Warning\":\"*May affect alertness and/or co-ordination. If affected, do not drive or operate machineryPDL Warn: Caution StrengthsSpecial handling and disposal required - ask your Pharmacist\",\"Direction\":\"\",\"GenericCode\":\"ME59\",\"GenericName\":\"MEDROXYPROGESTERONE\",\"Presentation\":\"Used to treat conditions such as absent or irregular menstrual periods, or abnormal uterine bleeding. It is also usedto decrease the risk of endometrial hyperplasia (a condition that may lead to uterine cancer) \",\"AltBrand\":\"DEPO-PROVERA, DEPO-RALOVERA, DEPO-PROVERA\",\"DoNotCrush\":false,\"TradeName\":\"DEPO-PROVERA\",\"Formulation\":\"PFS\",\"Strength\":\"150mg/mL, 1mL\",\"Schedule\":\"4\",\"PackSize\":1,\"IsCytotoxic\":false,\"Authorized\":0,\"TSAuthorized\":\"0001-01-01T00:00:00Z\",\"ShelfLife\":0,\"Description\":\"\",\"UsePrintingDrugName\":false,\"PrintingDrugName\":\"\",\"PharmacyId\":\"69a4c85de2638b9f120f5052\",\"Usage\":0,\"DrugFullName\":\"DEPO-PROVERA 150mg/mL, 1mL PFS\",\"MedicationFullDetails\":\"DEPO-PROVERA 150mg/mL, 1mL PFS - MEDROXYPROGESTERONE (DEP4)\",\"Id\":\"666b96ecd8c5020e08dac6c3\",\"CreatedDate\":\"2024-06-14T01:03:40.986Z\",\"CreatedUserId\":\"\",\"LastUpdateUserId\":\"\",\"LastUpdateDate\":\"2025-10-10T23:37:32.904Z\",\"UpdateDeletedDate\":\"1900-01-01T00:00:00Z\",\"IsDeleted\":false},\"IsPreventBrandswap\":false,\"Swapped\":false,\"FreqXWeek\":0,\"PatientDocumentIds\":[],\"Id\":\"69c09788c20a3af6be4af35e\",\"CreatedDate\":\"2026-03-23T01:29:44.789Z\",\"CreatedUserId\":\"69b9dfa1c90b16fd0ae7a5d6\",\"LastUpdateUserId\":\"69b9dfa1c90b16fd0ae7a5d6\",\"LastUpdateUserName\":\"peacockluke\",\"LastUpdateDate\":\"2026-04-20T06:06:18.565893Z\",\"UpdateDeletedDate\":\"1900-01-01T00:00:00Z\",\"IsDeleted\":false}"),
    "69c09788c20a3af6be4af353",
    "");
CurrentCulture
"en-US"
CurrentUICulture
"en-US"

State

4/20/2026 6:06:20 AM (+34ms) Succeeded

Latency:
1.709s
Duration:
6ms

+1.691s Processing

Server:
ip-0a0006d5:1664
Worker:
50820912

+6ms Enqueued

Queue:
default

4/20/2026 6:06:18 AM Created